Role of simple biomarkers in predicting fibrosis progression in HCV infection.
World J. Gastroenterol., Dec;16(45):5710-5 (2010)
The APRI may be enhanced by the use of the FIBROSpect II in the estimation of fibrosis in chronic hepatitis C.
Clin. Chim. Acta., Jun;381(2):119-23 (2007)
Prevalence of Barrett's esophagus in patients with or without GERD symptoms: role of race, age, and gender.
Dig. Dis. Sci., Mar;54(3):572-7 (2009)
Chronic hepatitis C is a common associated with hepatic granulomas.
World J. Gastroenterol., Nov;14(41):6366-9 (2008)
Hepatocellular carcinoma prevalence and mortality in a male state prison population.
Public Health Rep., 124(1):120-6 (2009)
Visualizing hepatitis C virus infections in human liver by two-photon microscopy.
Gastroenterology., Oct;137(4):1448-58 (2009)
APRI: an easy and validated predictor of hepatic fibrosis in chronic hepatitis C.
J. Clin. Gastroenterol., Jul;40(6):535-42 (2006)
Non-invasive markers of hepatic fibrosis in patients co-infected with HCV and HIV: comparison of the APRI and FIB-4 index.
Clin. Chim. Acta., Nov;397(1-2):51-4 (2008)